Display Settings:

Format

Send to:

Choose Destination
    Ned Tijdschr Geneeskd. 2000 Aug 12;144(33):1596-8.

    [Congenital amegakaryocytic thrombocytopenia: indication for allogeneic stem cell transplantation].

    [Article in Dutch]

    Source

    Wilhelmina Kinderziekenhuis, afd. Hematologie en Stamceltransplantatie, AB Utrecht.

    Abstract

    In two neonates, girls, persistent thrombocytopenia was found, which afterwards proved to be caused by a megakaryocytosis. Congenital amegakaryocytic thrombocytopenia is a rare bone marrow failure in young children that is defined as thrombocytopenia with absent or markedly decreased megakaryocytes in the bone marrow. Untreated, amegakaryocytic thrombocytopenia progresses to marrow failure with pancytopenia. Allogeneic stem cell transplantation offers the only possibility for cure, and is successful in approximately half of the patients. Both patients were treated by stem cell transplantation, the one with a matched unrelated donor, the second with stem cells from her HLA-identical sister. The first patient died, the second recovered with a normal number of circulating thrombocytes of donor origin.

    PMID:
    10965369
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk